Arpeggio is a drug discovery company using transcriptional fingerprints to understand differences between healthy and diseased cell-states in order to prioritize compounds for drug development. We are seeking an experienced scientist with expertise in design and implementation of high-throughput screening methods to further catalyze our drug screening capabilities. The ideal candidate should have experience in cell-based high-throughput drug screening using high throughput sequencing-based readouts. Additional experience with CRISPR screening and/or transcriptomics is preferred.
The candidate will contribute to the development of novel methodologies designed to define transcriptional signatures reflective of biological activities. Once protocols are established, the candidate will be responsible for screening large chemical libraries in order to identify compounds capable of eliciting specific transcriptional signatures.
Salary: $80,000 - $120,000 a year
About Arpeggio Bio
Arpeggio combines nascent transcription data with machine learning to explore the activity of entire genomes, allowing an unprecedented view of disease states and responses to drugs. We have partnered with many pharmaceutical companies since our founding in 2017, and are now focused on using our platform for the development of a series of small molecules for the treatment of advanced cancers.